According to “News International,” MarketsandMarkets has estimated that the global animal vaccines market is in a growth phase and is estimated to be worth $5.8 billion in 2013. If this continues, it would reach $8.6 billion by 2018. MarketsandMarkets is a market research and consulting company.
Animal vaccines are divided into categories: animal vaccines, livestock, poultry, porcine, equine, aquaculture, and other animal vaccines. The growth is attributed to increasing animal diseases, especially zoonotic diseases, which are those that transfer from animal to human. However, the cost of storage and maintenance of the vaccines will also increase.
Europe and North America are the largest markets for animal vaccines globally, but the greater increase will likely be seen in areas like India, China, Australia and Brazil, as these countries are seeing a rising awareness about animal health.
The major players in the global animal vaccines market are Pfizer (Zoetis) (U.S.), Merck (U.S.), Sanofi-Aventis (France), Bayer HealthCare (Germany), Virbac (France), Novartis (Switzerland), Boehringer Ingelheim (Germany), Heska Corporation (U.S.), Bioniche Animal Health Canada Inc. (Canada), and Ceva (France).